Home/Filings/4/A/0001209191-21-068976
4/A//SEC Filing

Lo Andrew 4/A

Accession 0001209191-21-068976

CIK 0001703057other

Filed

Dec 9, 7:00 PM ET

Accepted

Dec 10, 2:36 PM ET

Size

5.7 KB

Accession

0001209191-21-068976

Insider Transaction Report

Form 4/AAmended
Period: 2021-12-03
Lo Andrew
Director
Transactions
  • Award

    Share Option (right to buy)

    2021-12-03+91,32591,325 total
    Exercise: $14.02Exp: 2031-12-03Common Shares (91,325 underlying)
Footnotes (2)
  • [F1]The original option award was listed as 86,938 which is an administrative error due to an incorrect the Black-Scholes calculation. The correct number of awarded options is 91,325.
  • [F2]The shares subject to such option vest and become exercisable annually in substantially equal installments over a three-year period, with the first tranche vested on December 3, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date

Issuer

AbCellera Biologics Inc.

CIK 0001703057

Entity typeother

Related Parties

1
  • filerCIK 0001679076

Filing Metadata

Form type
4/A
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 2:36 PM ET
Size
5.7 KB